Search results
Leerink Partnrs Weighs in on Intra-Cellular Therapies, Inc.’s FY2025 Earnings (NASDAQ:ITCI)
ETF DAILY NEWS· 10 hours ago(NASDAQ:ITCI – Free Report) – Analysts at Leerink Partnrs raised their FY2025 earnings estimates for Intra-Cellular Therapies in a note issued to investors on Tuesday, May ...
Apollomics (NASDAQ:APLM) PT Lowered to $2.00 at HC Wainwright
ETF DAILY NEWS· 14 hours agoApollomics (NASDAQ:APLM – Free Report) had its price objective trimmed by HC Wainwright from $5.00 to $2.00 in a research note issued to investors on Wednesday morning, Benzinga ...
Coya Therapeutics (NASDAQ:COYA) Stock Rating Reaffirmed by Chardan Capital
ETF DAILY NEWS· 15 hours agoCoya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reiterated by Chardan Capital in a note issued to investors on Thursday, Benzinga reports. They ...
Earnings call: ClearPoint Neuro sees robust Q1 growth with diverse revenue streams By Investing.com
Investing.com· 2 days agoThis growth was driven by significant gains in biologics and drug delivery, as well as capital...
Inogen (NASDAQ:INGN) Earns Hold Rating from Needham & Company LLC
ETF DAILY NEWS· 9 hours agoNeedham & Company LLC reissued their hold rating on shares of Inogen (NASDAQ:INGN – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports ...
The Inventor of the Chatbot Tried to Warn Us About A.I.
The New Republic via Yahoo News· 3 days agoThe book is dotted with equations and scraps of code, almost as if he were working out some thoughts...
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
GuruFocus.com via Yahoo Finance· 3 days agoFunctional Neurosurgery, Navigation, and Therapy Revenue: Declined 18% to $1.9 million in Q1 2024. Capital Equipment and Software Revenue: Increased 255% ...
Leerink Partnrs Comments on Trevi Therapeutics, Inc.’s FY2024 Earnings (NASDAQ:TRVI)
ETF DAILY NEWS· 12 hours agoTrevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Stock analysts at Leerink Partnrs cut their FY2024 EPS estimates for Trevi Therapeutics in a research note issued to ...
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $15.40
ETF DAILY NEWS· 14 hours agoChardan Capital reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Tenaya Therapeutics in a research note on Thursday, March 21st. Finally, HC Wainwright ...
Perspective Therapeutics, Inc. Forecasted to Earn FY2024 Earnings of ($0.12) Per Share...
ETF DAILY NEWS· 11 hours agoPerspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Free Report) – Equities research analysts at Lifesci Capital issued their FY2024 earnings per share (EPS) estimates for shares of Perspective ...